Ovarian Cancer Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Ovarian Cancer Information Center has current, evidence-based information for you. Get the facts about ovarian cancer prevention, early detection, treatment, and survivorship, and stay up to date with ongoing ovarian cancer research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Ovarian Cancer Community is the leading Social Media Application for Ovarian Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
Women with BRCA 1/2 mutations who use oral contraceptives have a significantly reduced risk of ovarian cancer and a non-significantly increased risk of breast cancer The Highlights: Advances in Screening and Management of Ovarian Cancer
News from annual meetings of the Society of Gynecologic Oncology and the American... Cediranib Improves Survival in Recurrent Ovarian Cancer
Cediranib given with chemotherapy and as maintenance therapy improved survival in women with recurrent ovarian cancer.
By Barbara A. Goff, MD, President, Society of Gynecologic Oncology and Foundation... 10 Things Every Woman Should Know About Ovarian Cancer
Critical tips about screening and what to expect during treatment. Newly Diagnosed with Ovarian Cancer? Know This.
Critical steps and information for newly diagnosed women Ovarian cancer is known...
Ovarian Cancer Management
Brenda Maxwell, 59 Fishkill, New York I was busy as a wife, mom, and grandmother... National Ovarian Cancer Coalition Advocate Profile
Tracy Carmon, 42 Keller, Texas Tracy Carmon’s passion for advocacy is, in her... National Ovarian Cancer Coalition
Where do you go when you’re first delivered the news: “You have cancer”? For...
Ovarian Cancer Clinical Trials
GOG0213 – AA Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer
GOG-0218 – Phase III Trial of Carboplatin and Paclitaxel Plus Placebo versus Carboplatin and Paclitaxel Plus Concurrent Bevacizumab followed by Placebo, versus Carboplatin and Paclitaxel Plus Concurrent and Extended Bevacizumab, in Women with Newly Diagnosed, Previously Untreated, Suboptimal Advanced Stage Epithelial Ovarian and Primary Peritoneal Cancer
INST0708C – Biological Study: Assessment of Genetic Alterations in the Signaling Network as Prognostic Markers in Ovarian Cancer